HIV 1 News and Research

RSS

When should teenage girls have their gynecologic visit?

Parents of young teenage girls are probably thinking about how to help them navigate social media, classwork, and their social lives.

17 Dec 2019

Combination of two antibiotics eradicates latent tuberculosis in macaques

A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB.

17 Dec 2019

Novel drug from Amazon rainforest tree sap evaluated for treatment of chronic idiopathic diarrhea in non-HIV patients

A drug purified and developed from the sap of a tree in the Amazon rainforest is now being studied for the treatment of chronic idiopathic diarrhea in non-HIV patients at The University of Texas Health Science Center at Houston as part of a two-year pilot study.

16 Dec 2019

Homeless rape victims are not seeking post-sexual assault medical care

Nearly three-fourths of young adults experiencing homelessness who are raped do not seek post-sexual assault medical care, missing an opportunity to greatly reduce their risk of contracting HIV, according to a survey led by The University of Texas Health Science Center at Houston.

16 Dec 2019

Study shows non-TB lung infections rising; more in women and older people

Each year, more and more people are getting mycobacterial lung infections, and the total number living with such diseases is going up, according to a new study published in the journal Annals of the American Thoracic Society. Those at greatest risk are people above the age of 65 years and the elderly.

15 Dec 2019

Novel HIV vaccine shows promise

There are millions living with HIV and researchers have been working towards making a successful vaccine against the deadly infection for the past 35 years with no success. Now a new blueprint is being developed to prevent the infection.

15 Dec 2019

UAB seminar on the extraordinary science of the immune system

"The human immune system makes my head explode," Pulitzer Prize-winning journalist Matt Richtel recently told a University of Alabama at Birmingham freshman seminar on immunology. "This is by far the hardest subject I have ever had to explore."

15 Dec 2019

New structure for HIV-1 viral shell proposed

The matrix shell of the HIV-1 virus may have a different shape than previously thought, and a newly proposed model has significant implications for understanding how the virus functions, according to a new study by University of Alberta scientists.

14 Dec 2019

Rectal microbes could make a difference to the effectiveness of HIV vaccines

Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to researchers at the University of California, Davis. The work is published Dec. 11 in the journal mSphere.

13 Dec 2019

House drug pricing bill to reduce costs, improve access to life-saving therapies

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C.

13 Dec 2019

Bans restricting e-cigarette sales could do more harm than good, say experts

Bans and other policies restricting e-cigarette sales could do more public harm than good, according to a group of public-health, tobacco-policy and ethics experts.

13 Dec 2019

People living with HIV are willing to risk near-certain death in clinical trial

Nearly one-quarter of people living with HIV were willing to risk near-certain death in a clinical trial, if volunteering for the trial would help find a cure for the disease, according to the new study "HIV Cure Research."

13 Dec 2019

Efforts to prevent new HIV transmissions must also focus on people already living with HIV

Efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV, National Institutes of Health experts assert in the third of a series of JAMA commentaries.

11 Dec 2019

Nano-sized vesicles released by bacteria may protect against HIV infection

Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection, suggests a study of human cells and tissues by researchers at the National Institutes of Health and the University of Bologna, Italy. Known as extracellular vesicles, these bubble-like particles are produced by many kinds of cells and are thought to transport molecules from one cell to another.

11 Dec 2019

High HIV infection rates attributed to transgender community's social stigmatization and isolation

Although HIV infection rates are high among the transgender community in Russia, many transgender people know very little about the virus, as well as their own health status.

9 Dec 2019

Experts say cancer research is making more progress that people think

The focus on a “cure for cancer” is masking progress made in extending lifespan and making cancer manageable in the long-term.

9 Dec 2019

New approach to broadly acting, highly effective HIV vaccine

Researchers have reported a major advance in the creation of a successful HIV vaccine that is not produced by the host animal.

9 Dec 2019

New technique holds promise in cancer research and science studies

A new technique reported this week in Science overcomes several limitations of typical high-throughput chemical screens conducted on cell samples. Such screens are commonly used to try to discover new cancer drugs, and in many other biomedical applications.

8 Dec 2019

Common first-line treatment for cryptococcal meningitis in being compromised by drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

8 Dec 2019

Common treatment for cryptococcal meningitis compromised by emergence of drug resistance

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

6 Dec 2019